Abstract: A computing system is provided for modeling a deployment of heterogeneous memory on a server network. The computing system receives a user input of parameters including a memory ratio of local memory to heterogeneous memory in each server, a first relative throughput when an entire dataset is in local memory on a server, and a second relative throughput when the entire dataset is in heterogeneous memory on the server. Based on these parameters, the system determines a server ratio of a number of servers in an enhanced cluster with heterogeneous memory to a number of servers in a baseline cluster without heterogeneous memory, where the enhanced cluster and the baseline cluster deliver equivalent data throughput performance. Based on the parameters and the server ratio, a server network design is generated and outputted.

Abstract: A high load capacity shelving system that is easily accessible from all sides. The shelving system comprises a plurality of corner posts, a plurality of shelving assemblies, and Z-esque shaped support beams. The support beam has a first vertical component above and coplanar with a second vertical component, a first horizontal component extending from a bottom portion of the first vertical component, a second horizontal component extending from a bottom portion of the second vertical component, and a diagonal component connecting the first horizontal component to a top portion of the second vertical component. The first horizontal component and the second horizontal component are parallel to each other.

Abstract: This disclosure relates generally to cannabinoid derivatives having the structural formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives. In some embodiments, R1 is —CH2CH?C(CH3)2, R2 is methyl, R3 is CsHn, R4 is —C(O)N(R4a)(R4b), R5 is H, R6 is OH, and R7 is H. Compounds of the present disclosure were tested in agonist and antagonist mode for both the CB1 and CB2 receptors. The tested compounds were generally found to exhibit activity in antagonist mode at the CB1 and CB2 receptor.

Abstract: The present invention provides a lawn mower for cutting grass and maintaining the lawn surface. The lawn mower has a mower deck, a cutting blade driven by a motor, and a blade changing mechanism. The blade changing mechanism includes a fastener for securing the cutting blade to the motor, a blade securement tool for limiting the cutting blade from rotating, and at least one opening on the mower deck for removably receiving the blade securement tool. An edge guide is also provided on the mower deck. The lawn mower also includes a dynamic power management system configured to adjust a rotation speed of the motor dynamically based on a duty condition of the cutting blade.

Abstract: Disclosed herein is a method of using a hyaluronan conjugate, which includes a hyaluronic acid (HA), a sex hormone, and a linker for coupling one of the disaccharide units of the HA and the sex hormone. The hyaluronan conjugates are used in treating neurodegenerative diseases.

Abstract: Disclosed herein is a hyaluronan conjugate, which includes a hyaluronic acid (HA), a sex hormone, and a linker for coupling one of the disaccharide units of the HA and the sex hormone. Also disclosed herein are the uses of the hyaluronan conjugate in treating or preventing neurodegenerative diseases.

Abstract: This disclosure relates to cannabinoid derivatives of Formula (I), wherein R4 or R7 is a carboxamide group, pharmaceutical compositions comprising these compounds and methods of using the cannabinoid derivatives. These compounds are potential cannabinoid receptor inhibitors, including CB1 and CB2 receptors.

Abstract: This disclosure relates generally to cannabinoid derivatives having the formula (I), wherein R4 is hydrogen, —C(Q1)N(R4a)(R4b) or —C(R4J)(R4k)N(R4e)C(0)R4f, R6 is hydrogen, —C(Q2)N(R6a)(R6b) or —C(R6J)(R6k)N(R6e)C(0)R6f, provided that R6 is not hydrogen when R4 is hydrogen. Pharmaceutical compositions for the prevention or treatment of a disease associated with a cannabinoid receptor (such as CB1 or CB2) in a subject in need thereof, and methods of using the cannabinoid derivatives are also described.

Abstract: Disclosed herein is a method for preparing a hyaluronan-drug conjugate. The method uses the ethyl cyano(hydroxyimino)acetate/diisopropylcarbodiimide coupling system in a homogeneous reaction phase, which unexpectedly improves the substitution rate and substitution efficiency of hyaluronan-drug conjugates for various drugs.

Abstract: Disclosed herein is a method for preparing a hyaluronan-drug conjugate. The method uses the ethyl cyano(hydroxyimino)acetate/diisopropylcarbodiimide coupling system in a homogeneous reaction phase, which unexpectedly improves the substitution rate and substitution efficiency of hyaluronan-drug conjugates for various drugs.

Abstract: Disclosed herein is a hyaluronan conjugate, which includes a hyaluronic acid (HA), a sex hormone, and a linker for coupling one of the disaccharide units of the HA and the sex hormone. Also disclosed herein are the uses of the hyaluronan conjugate in treating or preventing neurodegenerative diseases.

Abstract: The present invention discloses use of butylidenephthalide (Bdph), a method of using the same, and a method for preparing a pharmaceutical composition containing the same. Because Bdph has the capability of promoting the hair growth and reducing the ?-amyloid protein (A?) level in nerve cells, the efficacy of improving the health and appearance of a subject can be achieved by administrating an effective amount of Bdph to the subject. Specifically, the Bdph has the efficacy of preventing or treating neurodegenerative diseases such as Alzheimer's disease caused by excessive build up of A? in the cells, and as an active ingredient in a topical composition, the Bdph is effective in promoting the hair growth at the site where the Bdph is administered.

Abstract: The present invention discloses use of butylidenephthalide (Bdph), a method of using the same, and a method for preparing a pharmaceutical composition containing the same. Because Bdph has the capability of promoting the hair growth and reducing the ?-amyloid protein (A?) level in nerve cells, the efficacy of improving the health and appearance of a subject can be achieved by administrating an effective amount of Bdph to the subject. Specifically, the Bdph has the efficacy of preventing or treating neurodegenerative diseases such as Alzheimer's disease caused by excessive build up of A? in the cells, and as an active ingredient in a topical composition, the Bdph is effective in promoting the hair growth at the site where the Bdph is administered.

Abstract: A micro-channel reaction apparatus includes a first mixing device and a first jetting device. The first mixing device includes a first inflow channel and a second inflow channel respectively used to direct a first fluid and a second fluid into the micro-channel reaction apparatus. The first jetting device includes a first tapering portion and a first flared portion, wherein one end of the first tapering portion is connected to the first inflow channel and the second inflow channel; another end of the first tapering portion is connected to the first flared portion; and the first tapering portion has a contract ratio of inner diameter ranging from 0.1 to 0.75.

Abstract: Exemplary embodiments or implementations are disclosed of methods, apparatus, and systems for operating motors in variable speed situations. In an exemplary implementation, a method of controlling a variable-speed motor includes defining a control duration as a predetermined number of cycles of a multiple-phase power supply. Each speed in a range of speeds is defined by a corresponding number of the cycles of the control duration. Power is provided to the motor from the power supply at a selected one of the speeds, by enabling input from the power supply for the number of the cycles of the control duration corresponding to the selected speed.

Abstract: The present invention discloses use of butylidenephthalide (Bdph), a method of using the same, and a method for preparing a pharmaceutical composition containing the same. Because Bdph has the capability of promoting the hair growth and reducing the ?-amyloid protein (A?) level in nerve cells, the efficacy of improving the health and appearance of a subject can be achieved by administrating an effective amount of Bdph to the subject. Specifically, the Bdph has the efficacy of preventing or treating neurodegenerative diseases such as Alzheimer's disease caused by excessive build up of A? in the cells, and as an active ingredient in a topical composition, the Bdph is effective in promoting the hair growth at the site where the Bdph is administered.

Abstract: Disclosed are exemplary embodiments of systems and methods for connecting split HVAC systems (and/or for providing such connectivity) to networks and/or smart meters, thereby allowing a split HVAC system to be controllable via the Internet and/or a smart meter. An exemplary embodiment includes a system for use with a split HVAC system having at least one outdoor unit and at least one indoor unit having a receiver. In this exemplary embodiment, the system comprises a control having connectivity to a network and/or a smart utility meter. An equipment interface module is configured for wireless communication with the receiver of the at least one indoor unit and the control. The equipment interface module is operable for communicating instructions from the control to the receiver of the at least one indoor unit, thereby allowing operation of the at least one indoor unit to be controllable via the network and/or smart utility meter.

Abstract: The present invention discloses use of butylidenephthalide (Bdph), a method of using the same, and a method for preparing a pharmaceutical composition containing the same. Because Bdph has the capability of promoting the hair growth and reducing the ?-amyloid protein (A?) level in nerve cells, the efficacy of improving the health and appearance of a subject can be achieved by administrating an effective amount of Bdph to the subject. Specifically, the Bdph has the efficacy of preventing or treating neurodegenerative diseases such as Alzheimer's disease caused by excessive build up of A? in the cells, and as an active ingredient in a topical composition, the Bdph is effective in promoting the hair growth at the site where the Bdph is administered.

Abstract: Exemplary embodiments or implementations are disclosed of systems for providing heat for use inside a structure and control apparatus and methods relating to material drying systems. In an exemplary embodiment, a control apparatus for controlling heat and/or humidity inside a structure selects one or more heat sources from a plurality of heterogeneous heat sources. The heat sources include a heat storage reservoir and a heat pump system between which heat is selectively transferrable via a fluid of the heat storage reservoir and a refrigerant of the heat pump system. The selecting is performed based on sensor input(s). The control apparatus controls the selected heat source(s) to provide heat inside the structure.

Abstract: Exemplary embodiments or implementations are disclosed of methods, apparatus, and systems for operating motors in variable speed situations. In an exemplary implementation, a method of controlling a variable-speed motor includes defining a control duration as a predetermined number of cycles of a multiple-phase power supply. Each speed in a range of speeds is defined by a corresponding number of the cycles of the control duration. Power is provided to the motor from the power supply at a selected one of the speeds, by enabling input from the power supply for the number of the cycles of the control duration corresponding to the selected speed.